Table 2.
UAS7, DASS-21s, FC-19s of patients according to demographic and clinical features.
| UAS7 median (IQR: 25‒75) |
FC-19 (mean SD) |
DASS-21t median (IQR: 25‒75) |
|||||
|---|---|---|---|---|---|---|---|
| BP | QP | RTNP | QP | RTNP | QP | RTNP | |
| Sex | |||||||
| Female | 2 (0‒5.5) | 5 (0‒18) | 3 (0‒12) | 19.25 ± 7.93 | 17.31 ± 7.19 | 7 (2.5‒14.5) | 3 (1‒9) |
| Male | 3 (0‒8) | 6 (0‒12) | 4 (0‒9) | 15.04 ± 8.07 | 14 ± 8.15 | 6 (0‒14) | 1 (0‒9) |
| p | NS | NS | NS | 0.024 | NS | NS | NS |
| Age | |||||||
| 18‒40 | 2 (0‒5.25) | 4.5 (0‒14.25) | 3 (0‒7.5) | 18.45 ± 7.66 | 16.64 ± 6.49 | 8 (1‒14) | 3 (0‒10.5) |
| 40‒65 | 4 (0‒8.5) | 7 (0‒19.5) | 4 (0‒12.5) | 18.34 ± 8.52 | 16.7 ± 8.29 | 7 (1.5‒13.5) | 3 (1‒9) |
| > 65 | 0 (0‒0) | 0 (0‒21) | 0 (0‒15) | 14 ± 5.09 | 11.5 ± 3.11 | 3.5 (0‒9.25) | 3 (0‒9) |
| p | NS | NS | NS | NS | NS | NS | NS |
| Presence of angioedema | 2 (0‒6) | 5 (0‒15) | 3 (0‒7.5) | 18.94 ± 8.13 | 17.09 ± 7.66 | 9 (3‒14.25) | 3.5 (1‒10) |
| p | NS | NS | NS | NS | NS | NS | NS |
| Presence of chronic diseases | 1 (0‒7) | 10.5 (0‒21.75) | 4.5 (0‒14) | 18.67 ± 8.44 | 16.67 ± 8.02 | 6 (1‒11) | 3 (0‒8.25) |
| p | NS | NS | NS | NS | NS | NS | NS |
UAS-7, Seven Days Urticaria Activity Score; DASS-21, Depression Anxiety and Stress Scale; FC-19, Fear of COVID-19 scale; IQR, Interquartile Range; SD, Standart Deviation; BP, Before Pandemic; QP, Quarantine Period; RTNP, Return to Normal Period; NS, Not Significant.